A safety monitoring system flagged that U.S. drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to preliminary data analyzed by U.S. health authorities.

Source: https://financialpost.com/pmn/business-pmn/u-s-fda-cdc-see-early-signal-of-possible-pfizer-bivalent-covid-shot-link-to-stroke

BioNTech’s revenue was down 80.0% compared to the same quarter last year.

Source: https://www.dailypolitical.com/2023/05/20/biontech-nasdaqbntx-rating-increased-to-buy-at-redburn-partners.html

“Charges which originated at BioNTech’s end have largely already been reflected in our 2022 financial results and to a smaller extent were continued to be reflected during 2023,” Jens Holstein, head of finance, said.

Source: https://www.shorenewsnetwork.com/2023/11/06/biontech-cuts-2023-revenue/

U.S. drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to preliminary data analyzed by U.S. health authorities.

Source: https://financialpost.com/pmn/business-pmn/u-s-says-pfizers-bivalent-covid-shot-may-be-linked-to-stroke-in-older-adults